Chanice Henry | 08/02/2015
The CRISPR tool has attracted worldwide attention from the R&D industry in regards to its capabilities for gene editing.CRISPR alongside the use of the Cas9 protein enables the ability to target a specific section of a gene sequence and edit it – by deleting and sometimes replacing the function with a new element. Until CRISPR’s discovery by Jennifer Doudna and her lab in 2013, options were relatively limited in regards to precise gene editing. This new technique acts as a tool to...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More